| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.31 | 0.09 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |